Yuji Saito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuji Saito has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Koichi Nagashima
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
9 shared publications - Shu Hirata
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
9 shared publications - Ryuta Watanabe
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
8 shared publications - Yasuo Okumura
Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
8 shared publications - Yuji Wakamatsu
Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610
6 shared publications Masanaru Sawada
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
5 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (6)
Posterior Pulmonary Vein Isolation Lesion Spacing and Left Atrial Posterior Wall Narrowing During Pulsed Field Ablation
Background: Left atrial posterior wall (LAPW) narrowing after excessive extension of bilateral pulmonary vein isolation (PVI) lines during pulsed field ablation (PFA) may create a proarrhythmic substrate. The CARTO 3‐integrated variable‐loop circular catheter (VLCC) provides real‐time tissue proximity indication (TPI) and ablation‐tag location, but their relationship with LAPW narrowing remains unclear. Therefore, we evaluated associations of TPI status and inter‐tag distance (ITD) with acute LAPW narrowing and whether an ITD‐guided workflow was associated with LAPW preservation. Methods: Fifty‐two retrospective and 27 prospective atrial fibrillation patients underwent PFA using a VLCC. In the retrospective phase, we evaluated the association between ITD, measured using TPI‐positive tags and all tags, and LAPW narrowing (< 10 mm) and derived a cutoff. In the prospective phase, the ITD‐guided workflow was applied, and we assessed residual LAPW band width. Results: In the retrospective phase, both TPI‐positive‐tag ITD and all‐tag ITD correlated with LAPW band width ( r = 0.63 and 0.70, respectively; both p < 0.001). All‐tag ITD showed a numerically higher AUC for LAPW narrowing than TPI‐positive‐tag ITD (0.869 vs. 0.795; p = 0.099), with an optimal all‐tag ITD cutoff of 16.5 mm. In the prospective phase incorporating the all‐tag ITD cutoff, residual LAPW band widths were wider at the roof (19.4 ± 7.9 vs. 25.1 ± 7.1 mm; p = 0.002) and carina (13.6 ± 7.1 vs. 20.8 ± 8.0 mm; p < 0.001) than in the retrospective phase. Conclusions: An all‐tag ITD‐guided workflow was associated with greater preservation of the residual LAPW band width.
- 28 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (6)
Open AccessPosterior Pulmonary Vein Isolation Lesion Spacing and Left Atrial Posterior Wall Narrowing During Pulsed Field Ablation
Background: Left atrial posterior wall (LAPW) narrowing after excessive extension of bilateral pulmonary vein isolation (PVI) lines during pulsed field ablation (PFA) may create a proarrhythmic substrate. The CARTO 3‐integrated variable‐loop circular catheter (VLCC) provides real‐time tissue proximity indication (TPI) and ablation‐tag location, but their relationship with LAPW narrowing remains unclear. Therefore, we evaluated associations of TPI status and inter‐tag distance (ITD) with acute LAPW narrowing and whether an ITD‐guided workflow was associated with LAPW preservation. Methods: Fifty‐two retrospective and 27 prospective atrial fibrillation patients underwent PFA using a VLCC. In the retrospective phase, we evaluated the association between ITD, measured using TPI‐positive tags and all tags, and LAPW narrowing (< 10 mm) and derived a cutoff. In the prospective phase, the ITD‐guided workflow was applied, and we assessed residual LAPW band width. Results: In the retrospective phase, both TPI‐positive‐tag ITD and all‐tag ITD correlated with LAPW band width ( r = 0.63 and 0.70, respectively; both p < 0.001). All‐tag ITD showed a numerically higher AUC for LAPW narrowing than TPI‐positive‐tag ITD (0.869 vs. 0.795; p = 0.099), with an optimal all‐tag ITD cutoff of 16.5 mm. In the prospective phase incorporating the all‐tag ITD cutoff, residual LAPW band widths were wider at the roof (19.4 ± 7.9 vs. 25.1 ± 7.1 mm; p = 0.002) and carina (13.6 ± 7.1 vs. 20.8 ± 8.0 mm; p < 0.001) than in the retrospective phase. Conclusions: An all‐tag ITD‐guided workflow was associated with greater preservation of the residual LAPW band width.
- Open Access
- 21 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Irrigation-dependent acute ganglionated plexus modulation during variable-loop pulsed field ablation
Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.
- 21 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Open AccessIrrigation-dependent acute ganglionated plexus modulation during variable-loop pulsed field ablation
Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- Open Access
- 5 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2) , e70329
Prevalence and Structured Approach to the Diagnoses of A on V Tachycardias
Background: “A on V” tachycardia (AoV‐T) is classically considered suggestive of atrioventricular nodal reentrant tachycardia (AVNRT); emerging evidence suggests that other mechanisms may present with this electrogram pattern. Objective: To reassess the prevalence and electrophysiologic characteristics of nonconventional mechanisms underlying AoV‐T. Methods: We retrospectively reviewed 1484 consecutive electrophysiologic studies for narrow‐QRS tachycardia with His–atrial interval ≤ 70 ms at 10 centers (2015–2024). Diagnoses were adjudicated using atrial overdrive pacing (AOP), ventricular overdrive pacing (VOP), and His‐synchronized premature ventricular contractions (PVCs). Results: Mechanisms other than conventional AVNRT were identified in 24 patients (1.6%): atrial tachycardia (AT, n = 7), junctional tachycardia (JT, n = 6), orthodromic reciprocating tachycardia via an NV pathway (NV‐ORT, n = 6) or an NF pathway (NF‐ORT, n = 1), and AVNRT with a bystander NV pathway ( n = 4). AT arose from the crista terminalis ( n = 4) or para‐Hisian region ( n = 3) and was diagnosed by V‐A‐A‐V response following VOP and/or absence of VA linking during differential AOP; dual AV nodal physiology was frequently observed. JT was diagnosed with atrial extrastimulus and/or A‐H‐H‐A response after AOP. NV/NF‐ORT was diagnosed by combined findings, including tachycardia reset/termination with His‐refractory PVCs, short PPI – TCL, orthodromic His capture, and V‐V‐A response following VOP; QRS fusion favored NV‐ORT. AVNRT with a bystander NV pathway was distinguished from NV‐ORT by pacing responses consistent with AVNRT despite evidence of NV conduction. Conclusion: Although AVNRT predominates in AoV‐T, a small subset of cases reflects AT, JT, NV/NF‐ORT, or AVNRT with a bystander NV pathway. Comprehensive pacing maneuvers are essential to avoid misclassification.
- 5 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2) , e70329
Open AccessPrevalence and Structured Approach to the Diagnoses of A on V Tachycardias
Background: “A on V” tachycardia (AoV‐T) is classically considered suggestive of atrioventricular nodal reentrant tachycardia (AVNRT); emerging evidence suggests that other mechanisms may present with this electrogram pattern. Objective: To reassess the prevalence and electrophysiologic characteristics of nonconventional mechanisms underlying AoV‐T. Methods: We retrospectively reviewed 1484 consecutive electrophysiologic studies for narrow‐QRS tachycardia with His–atrial interval ≤ 70 ms at 10 centers (2015–2024). Diagnoses were adjudicated using atrial overdrive pacing (AOP), ventricular overdrive pacing (VOP), and His‐synchronized premature ventricular contractions (PVCs). Results: Mechanisms other than conventional AVNRT were identified in 24 patients (1.6%): atrial tachycardia (AT, n = 7), junctional tachycardia (JT, n = 6), orthodromic reciprocating tachycardia via an NV pathway (NV‐ORT, n = 6) or an NF pathway (NF‐ORT, n = 1), and AVNRT with a bystander NV pathway ( n = 4). AT arose from the crista terminalis ( n = 4) or para‐Hisian region ( n = 3) and was diagnosed by V‐A‐A‐V response following VOP and/or absence of VA linking during differential AOP; dual AV nodal physiology was frequently observed. JT was diagnosed with atrial extrastimulus and/or A‐H‐H‐A response after AOP. NV/NF‐ORT was diagnosed by combined findings, including tachycardia reset/termination with His‐refractory PVCs, short PPI – TCL, orthodromic His capture, and V‐V‐A response following VOP; QRS fusion favored NV‐ORT. AVNRT with a bystander NV pathway was distinguished from NV‐ORT by pacing responses consistent with AVNRT despite evidence of NV conduction. Conclusion: Although AVNRT predominates in AoV‐T, a small subset of cases reflects AT, JT, NV/NF‐ORT, or AVNRT with a bystander NV pathway. Comprehensive pacing maneuvers are essential to avoid misclassification.
- Open Access
- 4 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Contact Index–Guided Pulsed Field Ablation: A Two‐Phase Validation of the Impedance Change Threshold to Prevent Acute Pulmonary Vein Gaps
Background: Pulsed field ablation (PFA) for atrial fibrillation (AF) requires adequate catheter–tissue contact. The Contact Index visualizes impedance change for the pentaspline catheter, but a validated contact threshold is unknown. Objective: The objective of this study is to define an impedance‐change cutoff that predicts sufficient contact to prevent acute pulmonary vein gaps (PVG) during pulmonary vein isolation (PVI), and to validate Contact–Index‐guided PVI. Methods: A prospective, single‐center, two‐phase study was performed. Phase 1 ( n = 10) measured impedance change (%) at eight antral segments per vein immediately before PFA in basket and flower configurations; the larger per‐segment value was analyzed. Post‐PVI high‐density voltage mapping (PVG ≥ 0.5 mV) was the reference; a receiver operating characteristic analysis identified the cutoff. Phase 2 ( n = 26) delivered energy only when all target splines met/exceeded the cutoff value obtained from Phase 1. Results: In Phase 1, PVG occurred in 13/320 segments across 2/10 patients (4/40 veins). Impedance change was lower at PVG‐positive than PVG‐negative segments (median 2 [0–6.5]% vs. 24 [17–32]%, p < 0.001). The cutoff value obtained from Phase 1 was ≥ 10% (area under the curve 0.99; sensitivity 100%; specificity 92.1%). In Phase 2, enforcing ≥ 10% yielded no patient‐level PVG (0/26 vs. 2/10; p = 0.07) and fewer gaps per vein (0/104 vs. 4/40; p = 0.005) and per segment (0/832 vs. 13/320; p < 0.001) compared with Phase 1. Procedure time, PVI time, fluoroscopy time, and total applications were similar between phases. Conclusions: An impedance‐change threshold of ≥ 10% on the Contact Index reliably indicates adequate contact with the pentaspline catheter and, when enforced, reduces acute PVG without prolonging procedures.
- 4 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Open AccessContact Index–Guided Pulsed Field Ablation: A Two‐Phase Validation of the Impedance Change Threshold to Prevent Acute Pulmonary Vein Gaps
Background: Pulsed field ablation (PFA) for atrial fibrillation (AF) requires adequate catheter–tissue contact. The Contact Index visualizes impedance change for the pentaspline catheter, but a validated contact threshold is unknown. Objective: The objective of this study is to define an impedance‐change cutoff that predicts sufficient contact to prevent acute pulmonary vein gaps (PVG) during pulmonary vein isolation (PVI), and to validate Contact–Index‐guided PVI. Methods: A prospective, single‐center, two‐phase study was performed. Phase 1 ( n = 10) measured impedance change (%) at eight antral segments per vein immediately before PFA in basket and flower configurations; the larger per‐segment value was analyzed. Post‐PVI high‐density voltage mapping (PVG ≥ 0.5 mV) was the reference; a receiver operating characteristic analysis identified the cutoff. Phase 2 ( n = 26) delivered energy only when all target splines met/exceeded the cutoff value obtained from Phase 1. Results: In Phase 1, PVG occurred in 13/320 segments across 2/10 patients (4/40 veins). Impedance change was lower at PVG‐positive than PVG‐negative segments (median 2 [0–6.5]% vs. 24 [17–32]%, p < 0.001). The cutoff value obtained from Phase 1 was ≥ 10% (area under the curve 0.99; sensitivity 100%; specificity 92.1%). In Phase 2, enforcing ≥ 10% yielded no patient‐level PVG (0/26 vs. 2/10; p = 0.07) and fewer gaps per vein (0/104 vs. 4/40; p = 0.005) and per segment (0/832 vs. 13/320; p < 0.001) compared with Phase 1. Procedure time, PVI time, fluoroscopy time, and total applications were similar between phases. Conclusions: An impedance‐change threshold of ≥ 10% on the Contact Index reliably indicates adequate contact with the pentaspline catheter and, when enforced, reduces acute PVG without prolonging procedures.
- Open Access
- 26 December 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (6)
Undiagnostic Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation Patients Undergoing Catheter Ablation
Background: Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist, but the prevalence of HFpEF among AF patients undergoing catheter ablation (CA) remains unclear. Methods: We studied 127 AF patients with preserved ejection fraction (≥ 50%) undergoing initial CA. The Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptides, Functional testing, and Final etiology (HFA‐PEFF) score was assessed 2 weeks before and 1 year after CA. Patients were grouped as low (0–1), intermediate (2–4), or high (5–6). The primary endpoint was AF freedom at 1 and 2 years; secondary endpoints were changes in HFA‐PEFF score; tertiary endpoint was predictors of score improvement. Results: Of 127 patients, 30 (23.6%) had HFpEF (score ≥ 5), 76 (59.8%) suspected (2–4), and 21 (16.5%) unlikely (≤ 1). Median follow‐up 24.4[ 12.5–29.5] months. AF freedom at 1 year was high (86.4%, 91.7%, 89.7%; p = 0.66). Higher baseline score correlated with older age, female sex, hypertension, larger left atrial volume index (LAVI), elevated average E / e ′, and increased left ventricular mass index. We divided patients into two groups: those with ≥ 1‐point score improvement after CA ( n = 89, 70.1%) and those whose score remained unchanged or worsened ( n = 38, 29.9%). Improvement was associated with older age, larger LAVI, higher average E / e ′, and elevated N‐terminal pro‐B‐type natriuretic peptide. Multivariate analysis identified septal e' and LAVI as predictors. No patients had a score ≥ 5 at 1 year. Conclusions: HFpEF or suspected HFpEF was common in AF CA candidates but not linked to recurrence. CA remarkably improved HFpEF features, suggesting reversibility.
- 26 December 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (6)
Open AccessUndiagnostic Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation Patients Undergoing Catheter Ablation
Background: Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist, but the prevalence of HFpEF among AF patients undergoing catheter ablation (CA) remains unclear. Methods: We studied 127 AF patients with preserved ejection fraction (≥ 50%) undergoing initial CA. The Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptides, Functional testing, and Final etiology (HFA‐PEFF) score was assessed 2 weeks before and 1 year after CA. Patients were grouped as low (0–1), intermediate (2–4), or high (5–6). The primary endpoint was AF freedom at 1 and 2 years; secondary endpoints were changes in HFA‐PEFF score; tertiary endpoint was predictors of score improvement. Results: Of 127 patients, 30 (23.6%) had HFpEF (score ≥ 5), 76 (59.8%) suspected (2–4), and 21 (16.5%) unlikely (≤ 1). Median follow‐up 24.4[ 12.5–29.5] months. AF freedom at 1 year was high (86.4%, 91.7%, 89.7%; p = 0.66). Higher baseline score correlated with older age, female sex, hypertension, larger left atrial volume index (LAVI), elevated average E / e ′, and increased left ventricular mass index. We divided patients into two groups: those with ≥ 1‐point score improvement after CA ( n = 89, 70.1%) and those whose score remained unchanged or worsened ( n = 38, 29.9%). Improvement was associated with older age, larger LAVI, higher average E / e ′, and elevated N‐terminal pro‐B‐type natriuretic peptide. Multivariate analysis identified septal e' and LAVI as predictors. No patients had a score ≥ 5 at 1 year. Conclusions: HFpEF or suspected HFpEF was common in AF CA candidates but not linked to recurrence. CA remarkably improved HFpEF features, suggesting reversibility.
- Open Access
- 26 September 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (5) , e70199
Prospective Multicenter Registry to Investigate the Clinical Feasibility of Combination Workflow With 90 W/4 s and Ablation Index‐Guided 50 W Ablation (PRECISE—COMBO 90 W/50 W Study)
Background: High‐power short‐duration (HPSD) ablation is an established therapy for pulmonary vein (PV) isolation (PVI) in atrial fibrillation (AF), aiming to form efficient transmural lesions. Very HPSD (vHPSD) can further shorten ablation time but may increase the risk of acute PVI failure compared with HPSD. A combined HPSD and vHPSD strategy (90 W/50 W combination workflow) potentially balances efficiency and durability, though its clinical feasibility remains unknown. Therefore, this multicenter registry evaluated the acute and long‐term efficacy of a 90 W/50 W combination workflow for PVI in patients with paroxysmal AF. Methods: In this prospective study, a total of 101 consecutive patients with paroxysmal AF underwent PVI using radiofrequency ablation with a 90 W/50 W combination workflow. We evaluated acute outcomes, including first‐pass isolation and acute PV reconnection, and monitored atrial tachyarrhythmia recurrences over 12 months. Results: Median PVI procedure time was 35 min, with total procedure time at 105 min. First‐pass PVI was achieved in 58.4% of patients, including 74.3% in the right PV and 72.3% in the left PV. Acute PV reconnection occurred in 31.7% (32/101). In multivariate analysis, carina sites independently predicted acute PVI failure in both HPSD and vHPSD groups, while contact force also predicted failure in the HPSD group. After 1 year, 89.9% of patients remained free from documented atrial tachyarrhythmias. Conclusion: The 90 W/50 W combination workflow did not notably shorten procedure time or enhance first‐pass success. More standardized strategies, particularly in carina segments with higher contact force and ablation index under HPSD, may be required to ensure optimal lesion durability and favorable outcomes.
- 26 September 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (5) , e70199
Open AccessProspective Multicenter Registry to Investigate the Clinical Feasibility of Combination Workflow With 90 W/4 s and Ablation Index‐Guided 50 W Ablation (PRECISE—COMBO 90 W/50 W Study)
Background: High‐power short‐duration (HPSD) ablation is an established therapy for pulmonary vein (PV) isolation (PVI) in atrial fibrillation (AF), aiming to form efficient transmural lesions. Very HPSD (vHPSD) can further shorten ablation time but may increase the risk of acute PVI failure compared with HPSD. A combined HPSD and vHPSD strategy (90 W/50 W combination workflow) potentially balances efficiency and durability, though its clinical feasibility remains unknown. Therefore, this multicenter registry evaluated the acute and long‐term efficacy of a 90 W/50 W combination workflow for PVI in patients with paroxysmal AF. Methods: In this prospective study, a total of 101 consecutive patients with paroxysmal AF underwent PVI using radiofrequency ablation with a 90 W/50 W combination workflow. We evaluated acute outcomes, including first‐pass isolation and acute PV reconnection, and monitored atrial tachyarrhythmia recurrences over 12 months. Results: Median PVI procedure time was 35 min, with total procedure time at 105 min. First‐pass PVI was achieved in 58.4% of patients, including 74.3% in the right PV and 72.3% in the left PV. Acute PV reconnection occurred in 31.7% (32/101). In multivariate analysis, carina sites independently predicted acute PVI failure in both HPSD and vHPSD groups, while contact force also predicted failure in the HPSD group. After 1 year, 89.9% of patients remained free from documented atrial tachyarrhythmias. Conclusion: The 90 W/50 W combination workflow did not notably shorten procedure time or enhance first‐pass success. More standardized strategies, particularly in carina segments with higher contact force and ablation index under HPSD, may be required to ensure optimal lesion durability and favorable outcomes.
- 24 January 2025
- Published by Elsevier in Heart Rhythm
- Vol. 22 (7) , e51-e59
Clinical importance of tissue proximity indication during pulsed field ablation for atrial fibrillation: Insights from initial experience
- 24 January 2025
- Published by Elsevier in Heart Rhythm
- Vol. 22 (7) , e51-e59
Clinical importance of tissue proximity indication during pulsed field ablation for atrial fibrillation: Insights from initial experience
- 12 December 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (2) , 521-524
The Pitfalls of Capture/Fusion Beats: Diagnostic Challenges in Wide QRS Complex Tachycardia
- 12 December 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (2) , 521-524
The Pitfalls of Capture/Fusion Beats: Diagnostic Challenges in Wide QRS Complex Tachycardia
- 2 September 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (11) , 2248-2250
What is the mechanism of this narrow QRS tachycardia in a patient with type‐A Wolff‐Parkinson‐White (WPW) syndrome?
- 2 September 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (11) , 2248-2250
What is the mechanism of this narrow QRS tachycardia in a patient with type‐A Wolff‐Parkinson‐White (WPW) syndrome?